We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

86 hedge funds and large institutions have $416M invested in VanEck Pharmaceutical ETF in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,704% more call options, than puts

Call options by funds: $7.4M | Put options by funds: $410K

25% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 24

20% more capital invested

Capital invested by funds: $346M → $416M (+$69.7M)

12.76% more ownership

Funds ownership: 64.52% → 77.28% (+13%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 91 → 86 (-5)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

Holders
86
Holders Change
-5
Holders Change %
-5.49%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
30
Reduced
24
Closed
13
Calls
$7.4M
Puts
$410K
Net Calls
+$6.99M
Net Calls Change
+$3.31M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$128M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.53M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$3.72M
4
TRCT
Tower Research Capital (TRC)
New York
+$3.46M
5
LPL Financial
LPL Financial
California
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.13M
2
Jane Street
Jane Street
New York
-$2.69M
3
M&T Bank
M&T Bank
New York
-$2.2M
4
LJAC
L.J. Altfest & Co
New York
-$836K
5
Bank of America
Bank of America
North Carolina
-$799K
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
76
NewSquare Capital
Pennsylvania
$7K – – –
BBPWM
77
Blue Bell Private Wealth Management
Pennsylvania
$5K – – –
SPIA
78
Steward Partners Investment Advisory
New York
$5K – – –
MIM
79
Macroview Investment Management
Maryland
$4K +$1.77K +24 +62%
AIM
80
Anchor Investment Management
South Carolina
$3.9K – – –
GFPC
81
Global Financial Private Client
Florida
$3.47K -$179K -2,436 -98%
VanEck Associates
82
VanEck Associates
New York
$3K – – –
SWA
83
SOA Wealth Advisors
New York
$2K +$74 +1 +3%
MOS
84
MGO One Seven
Ohio
$949 -$13.3K -181 -1%
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$666 +$555K +7,541 +396%
M&T Bank
86
M&T Bank
New York
– -$2.2M -28,680 Closed
NL
87
NVWM LLC
Pennsylvania
– -$751K -9,776 Closed
Simplex Trading
88
Simplex Trading
Illinois
– -$618K -8,051 Closed
LNWWM
89
Laird Norton Wetherby Wealth Management
California
– -$538K -7,000 Closed
BCM
90
Barometer Capital Management
Ontario, Canada
– -$466K -5,900 Closed
BI
91
Berkeley Inc
Idaho
– -$411K -5,347 Closed
GCA
92
Greenwood Capital Associates
South Carolina
– -$400K -5,200 Closed
CIBC World Market
93
CIBC World Market
Ontario, Canada
– -$247K -3,212 Closed
FTA
94
Financial & Tax Architects
Missouri
– -$239K -3,114 Closed
Cetera Investment Advisers
95
Cetera Investment Advisers
Illinois
– -$232K -3,014 Closed
FPCM
96
Financial Partners Capital Management
New York
– -$201K -2,610 Closed
LFA
97
Level Financial Advisors
New York
– -$14K -178 Closed
JWA
98
JFS Wealth Advisors
Pennsylvania
– -$5K -64 Closed
1 2 3
4

PPH Hedge Fund Activity: Q3 2022 in Review

86 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2022, worth a combined $416M — up 20% from $346M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of PPH and 8 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 30 added.

The largest buyer was Goldman Sachs, adding an estimated $128M. The largest seller was Morgan Stanley, cutting an estimated $6.13M.

  • 86 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2022, down from 91 in Q2 2022.
  • Funds reported $416M of VanEck Pharmaceutical ETF stock for Q3 2022, up 20% quarter-over-quarter.
  • 8 funds opened new VanEck Pharmaceutical ETF positions in Q3 2022 and 13 closed out, a net change of -5 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2022 was Goldman Sachs, an estimated $128M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2022 was Morgan Stanley, an estimated $6.13M sold.

Based on aggregated 13F filings for Q3 2022.